Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Mar. 31, 2026
shares
| |
| Trading Arrangements, by Individual | |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Rahsaan Thompson [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On January 8, 2026, Rahsaan Thompson, our Chief Legal Officer, Secretary and Compliance Officer, adopted a Rule 10b5-1 trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 36,351 shares of our common stock. The plan will terminate at the earlier of the execution of all trading orders under the plan or January 9, 2027.
|
| Name | Rahsaan Thompson |
| Title | Chief Legal Officer, Secretary and Compliance Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | January 8, 2026 |
| Expiration Date | January 9, 2027 |
| Arrangement Duration | 366 days |
| Aggregate Available | 36,351 |
| Adrian W. Quartel [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On March 16, 2026, Adrian W. Quartel, our Chief Medical Officer, adopted a Rule 10b5-1 trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 225,000 shares of our common stock. The plan will terminate at the earlier of the execution of all trading orders under the plan or April 30, 2027.
|
| Name | Adrian W. Quartel |
| Title | Chief Medical Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | March 16, 2026 |
| Expiration Date | April 30, 2027 |
| Arrangement Duration | 366 days |
| Aggregate Available | 225,000 |
| Neil F. McFarlane [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On March 25, 2026, Neil F. McFarlane, our President and Chief Executive Officer, adopted a Rule 10b5-1 trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to (i) 144,999 shares of our common stock and (ii) such number of shares of our common stock that may vest, subject to the achievement of certain performance goals, under performance-based restricted stock units (“PSUs”) for 72,500 shares of our common stock granted to Mr. McFarlane on February 7, 2025. The plan will terminate at the earlier of the execution of all trading orders under the plan or June 23, 2027.
|
| Name | Neil F. McFarlane |
| Title | President and Chief Executive Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | March 25, 2026 |
| Expiration Date | June 23, 2027 |
| Arrangement Duration | 455 days |
| Neil F. McFarlane Trading Arrangement, Common Stock [Member] | Neil F. McFarlane [Member] | |
| Trading Arrangements, by Individual | |
| Aggregate Available | 144,999 |
| Neil F. McFarlane Trading Arrangement, Performance-Based Restricted Stock Units [Member] | Neil F. McFarlane [Member] | |
| Trading Arrangements, by Individual | |
| Aggregate Available | 72,500 |